SightfileU.S. market data from official filings

TANGO THERAPEUTICS INC (TNGX)

Name: TANGO THERAPEUTICS INC (TNGX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001819133 · EDGAR filings · Updated 2026-07-02

TANGO THERAPEUTICS INC (TNGX) has reported institutional ownership of 126.3%, with 194 institutional managers holding positions valued at $3.77B per the latest 13F reporting period.

Institutional ownership

126.3%

Institutional managers

194

Reported 13F value

$3.77B

Insider activity

27 trans.

−$28.3M net selling

Latest updates

2026-07-02 — Insider transaction reported (Form 4)
2026-06-23 — Insider transaction reported (Form 4)
2026-06-23 — Initial insider ownership filed (Form 3)
2026-06-23 — Current report (8-K) filed
2026-06-17 — Notice of proposed sale filed (Form 144)
2026-06-11 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, TANGO THERAPEUTICS INC has 194 institutional holders and institutional ownership of 126.3%.

Insider activity

Insiders reported 27 transactions (0 buys, 16 sells) across 11 reporting insiders, with a net reported value of −$28.3M.

Related companies

Newamsterdam Pharma Co NV (NAMS) · SOTERA HEALTH CO (SHC) · INDIVIOR PHARMACEUTICALS INC (INDV) · LIVANOVA PLC SHS (LIVN) · EDGEWISE THERAPEUTICS INC (EWTX) · CRISPR THERAPEUTICS AG (CRSP)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.